Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 11, 2007, Pages 23-30

  Upadhyaya, Himanshu P ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CENTRAL STIMULANT AGENT; COCAINE; DEXAMPHETAMINE; METHADONE; METHYLPHENIDATE; MOCLOBEMIDE; OPIATE; PEMOLINE; VENLAFAXINE;

ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INTOXICATION; DRUG MISUSE; DRUG RELEASE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DELAYED-ACTION PREPARATIONS; DIAGNOSTIC ERRORS; HUMANS; RISK FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 35349005318     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-1170
3. Barbaresi WJ, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder? incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med 2002;156:217-224
4. Faraone SV, Biederman J, Mick E, et al. Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry 2000;157:1077-1083
5. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? a meta-analytic review of the literature. Pediatrics 2003;111:179-185
6. Katusic SK, Barbaresi WJ, Colligan RC, et al. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005;15:764-776
7. Wilson JJ, Levin FR. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol 2005;15:751-763
8. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse 2004;39:1095-1116
9. Wilens TE, Gignac M, Swezey A, et al. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 2006;45:408-414
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
11. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 2004 National Survey on Drug Use and Health: National Findings. Rockville, Md: US Department of Health and Human Services; 2004. Available at: http://oas.samhsa.gov/nhsda/2k4nsduh/2k4results.htm. Accessed January 4, 2007
12. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future National Survey Results on Drug Use, 1975-2004: Volume 1, Secondary School Students. Bethesda, Md: National Institute on Drug Abuse; 2005. Available at: http://www.monitoringthefuture.org/pubs/monographs/vol1_2004.pdf. Accessed January 17, 2007
13. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005;57:1215-1220
14. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-1798
15. Wilens TE, Biederman J, Mick E, et al. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997;185:475-482
16. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004;27:283-301
17. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723
18. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993;34:75-82
19. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000;61:244-251
20. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? findings from a sample of adults with and without ADHD. Am J Addict 1998;7:156-163
21. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998;52:15-25
22. McCabe SE, Teter CJ, Boyd CJ, et al. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 2004;35:501-504
23. McCabe SE, Knight JR, Teter CJ, et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005;100:96-106
24. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 2006;54:269-278
25. Upadhyaya HP, Rose K, Wang W, et al. Attention deficit hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 2005;15:799-809
26. Teter CJ, McCabe SE, Cranford JA, et al. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health 2005;53:253-262
27. Spencer TJ, Biederman J, Ciccone PE, et al. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 2006;163:387-395
28. Khantzian EJ. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am J Psychiatry 1983;140:784-785
29. Khantzian EJ, Gawin F, Kleber HD, et al. Methylphenidate (Ritalin) treatment of cocaine dependency: a preliminary report. J Subst Abuse Treat 1984;1:107-112
30. Cocores JA, Davies RK, Mueller PS, et al. Cocaine abuse and adult attention deficit disorder. J Clin Psychiatry 1987;48:376-377
31. Cocores JA, Patel MD, Gold MS, et al. Cocaine abuse, attention deficit disorder, and bipolar disorder. J Nerv Ment Dis 1987;175:431-432
32. Cavanagh R, Clifford JS, Gregory WL. The use of bromocriptine for the treatment of attention deficit disorder in two chemically dependent patients. J Psychoactive Drugs 1989;21:217-220
33. Schubiner H, Tzelepis A, Isaacson JH, et al. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry 1995;56:146-150
34. Levin FR, Evans SM, McDowell DM, et al. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1998;59:300-305
35. Schubiner H, Saules K, Arfken C, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002;10:286-294
36. Upadhyaya HP, Brady KT, Sethuraman G, et al. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit hyperactivity disorder: a pilot study. J Clin Psychopharmacol 2001;21:116-118
37. Levin FR, Evans SM, McDowell DM, et al. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis 2002;21:1-16
38. Vaiva G, De Lenclave MB, Bailly D. Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:609-611
39. Riggs PD, Hall SK, Mikulich-Gilbertson SK, et al. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 2004;43:420-429
40. Solhkhah R, Wilens TE, Daly J, et al. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol 2005;15:777-786
41. Carpentier PJ, de Jong CA, Dijkstra BA, et al. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005;100:1868-1874
42. Levin FR, Evans SM, Brooks DJ, et al. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006;81:137-148
43. Levin FR, Evans SM, Brooks DJ, et al. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007;87:20-29
44. Grabowski J, Rhoades H, Stotts A, et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004; 29:969-981
45. Grabowski J, Rhoades H, Schmitz J, et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 2001;31:522-526
46. Shearer J, Wodak A, Matick R, et al. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 2001;96:1289-1296
47. Shearer J, Wodak A, van Beek I, et al. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 2003;98:1137-1141
48. Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998;37:331-332
49. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905-1907
50. Babor TF, de la Fuente JR, Saunders J, et al. The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Health Care. 2nd ed. Geneva, Switzerland: World Health Organization; 2001
51. Skinner HA. The drug abuse screening test. Addict Behav 1982;7:363-371
52. Schwartz RH, Wirtz PW. Potential substance abuse: detection among adolescent patients: using the Drug and Alcohol (DAP) Quick Screen, a 30-item questionnaire. Clin Pediatr 1990;29:38-43
53. Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002;156:607-614
54. Bukstein OG, Bernet W, Arnold V, et al, for the Work Group on Quality Issues for the American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 2005;44:609-621
55. Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs 2005;19:643-655